Apply Now: CFAR Supplements for "Ending the HIV Epidemic: A Plan for America"
March 10, 2019
New CFAR NIH Administrative Supplement Opportunity
This FY19 supplement opportunity is for eligible NIH Centers for AIDS Research (CFARs) and NIMH HIV/AIDS Research Centers (ARCs) to support planning activities at existing NIH HIV/AIDS centers to address the “Ending the HIV Epidemic: A Plan for America” (EtHE) initiative.
The goal of the supplements is to support implementation science research that addresses at least one of the key pillars of the EtHE initiative: Diagnose, Treat, Protect, and Respond. Specifically, the NIH will support CFAR/ARC investigators to collaborate with local partners and HHS agencies. It is expected that by the end of the planning project the team of CFAR/ARC investigators and local partners will have identified and designed a targeted implementation science research project that will support the local ending the HIV epidemic plans. These planning projects may include feasibility studies, especially if collaborations have already been established and are ongoing, with the possibility that successful projects would lead into expanded implementation science studies next year. (Basic science and clinical research other than implementation science are not eligible for this supplement.)
Applications must align with the NIH HIV/AIDS research priorities (NOT-OD-15-137) and the EtHE initiative. All faculty, including early and later stage investigators are eligible to be the supplement PI. The integration of early stage faculty and fellows with other CFAR/ARC investigators and local partners is encouraged to advance these planning projects within the context of a team building approach.
1) Interested investigators must submit a 1-page single-spaced outline
2) Outlines will be reviewed by the HU CFAR Developmental Core Review Committee and must include:
List of lead investigators and institutions
Pillar of the EtHE initiative that the science will address
Brief summary of rationale and approach
3) Three outlines will be selected to move forward for full submission to the NIH
Please submit your outline by 12 noon on Monday, March 18, 2019. Final decision as to which outlines will be selected to move forward will be made the following week.